Interplay between adiponectin and pro-atrial natriuretic peptide and prognosis in patients with ST-segment elevation myocardial infarction

American Journal of Cardiology

Volumn 116, Issue 9, 2015, Pages 1340-1345

  Lindberg, Søren ^a   Jensen, Jan S ^a,b   Hoffmann, Søren ^a   Pedersen, Sune H ^a   Iversen, Allan Z ^a   Galatius, Søren ^a   Frystyk, Jan ^c,d   Flyvbjerg, Allan ^c,d   Goetze, Jens P ^e   Bjerre, Mette ^c,d   Mogelvang, Rasmus ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANGIOPLASTY; BLOOD; HEART MUSCLE CONDUCTION SYSTEM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADIPONECTIN; AGED; ANGIOPLASTY; ATRIAL NATRIURETIC FACTOR; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84944352364     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.07.060     Document Type: Article

References (30)

1. R. Shibata, K. Sato, D.R. Pimentel, Y. Takemura, S. Kihara, K. Ohashi, T. Funahashi, N. Ouchi, and K. Walsh Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
2. M. Debinski, P.P. Buszman, K. Milewski, W. Wojakowski, W. Jackiewicz, J. Pajak, D. Szurlej, J. Fryc-Stanek, S. Wiernek, M. Jelonek, M.E. Spurlock, J. Martin, A. Bochenek, and P.E. Buszman Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model Int J Mol Med 27 2011 775 781
3. R. Schnabel, C.M. Messow, E. Lubos, C. Espinola-Klein, H.J. Rupprecht, C. Bickel, C. Sinning, S. Tzikas, T. Keller, S. Genth-Zotz, K.J. Lackner, T.F. Munzel, and S. Blankenberg Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
4. S. Pilz, H. Mangge, B. Wellnitz, U. Seelhorst, B.R. Winkelmann, B. Tiran, B.O. Boehm, and W. Marz Adiponectin and mortality in patients undergoing coronary angiography J Clin Endocrinol Metab 91 2006 4277 4286
5. L.C. Costello-Boerrigter, and J.C. Burnett Jr. A new role for the natriuretic peptides: metabolic regulators of the adipocyte J Am Coll Cardiol 53 2009 2078 2079
6. A.L. Birkenfeld, P. Budziarek, M. Boschmann, C. Moro, F. Adams, G. Franke, M. Berlan, M.A. Marques, F.C. Sweep, F.C. Luft, M. Lafontan, and J. Jordan Atrial natriuretic peptide induces postprandial lipid oxidation in humans Diabetes 57 2008 3199 3204
7. M. Bordicchia, D. Liu, E.Z. Amri, G. Ailhaud, P. Dessi-Fulgheri, C. Zhang, N. Takahashi, R. Sarzani, and S. Collins Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes J Clin Invest 122 2012 1022 1036
8. I.J. Neeland, B.R. Winders, C.R. Ayers, S.R. Das, A.Y. Chang, J.D. Berry, A. Khera, D.K. McGuire, G.L. Vega, J.A. de Lemos, and A.T. Turer Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile J Am Coll Cardiol 62 2013 752 760
9. S.G. Wannamethee, P. Welsh, P.H. Whincup, N. Sawar, M.C. Thomas, V. Gudnarsson, and N. Sattar High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 18 2011 65 71
10. T. Ohara, J. Kim, M. Asakura, H. Asanuma, S. Nakatani, K. Hashimura, H. Kanzaki, T. Funahashi, H. Tomoike, and M. Kitakaze Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects Hypertens Res 31 2008 825 831
11. O. Tsukamoto, M. Fujita, M. Kato, S. Yamazaki, Y. Asano, A. Ogai, H. Okazaki, M. Asai, Y. Nagamachi, N. Maeda, Y. Shintani, T. Minamino, M. Asakura, I. Kishimoto, T. Funahashi, H. Tomoike, and M. Kitakaze Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure J Am Coll Cardiol 53 2009 2070 2077
12. S. Lindberg, S.H. Pedersen, R. Mogelvang, M. Bjerre, J. Frystyk, A. Flyvbjerg, S. Galatius, and J.S. Jensen Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol 109 2012 492 496
13. S. Lindberg, J.S. Jensen, S. Hoffmann, A. Iversen, S.H. Pedersen, R. Mogelvang, S. Galatius, A. Flyvbjerg, and M. Bjerre Osteoprotegerin levels change during STEMI and reflect cardiac function Can J Cardiol 30 2014 1523 1528
14. M. Madsen, M. Davidsen, S. Rasmussen, S.Z. Abildstrom, and M. Osler The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry J Clin Epidemiol 56 2003 124 130
15. J. Frystyk, L. Tarnow, T.K. Hansen, H.H. Parving, and A. Flyvbjerg Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications Diabetologia 48 2005 1911 1918
16. R.V. Kettunen, J. Leppaluoto, A. Jounela, and O. Vuolteenaho Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction Am Heart J 127 1994 1449 1455
17. I. Hunter, U. Alehagen, U. Dahlstrom, J.F. Rehfeld, D.L. Crimmins, and J.P. Goetze N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification Clin Chem 57 2011 1327 1330
18. G. Vervoort, J.M. Klein Gunnewiek, H.L. Willems, and J.F. Wetzels Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR Nephrol Dial Transpl 21 2006 2998 2999
19. S. Engeli, A.L. Birkenfeld, P.M. Badin, V. Bourlier, K. Louche, N. Viguerie, C. Thalamas, E. Montastier, D. Larrouy, I. Harant, I. de Glisezinski, S. Lieske, J. Reinke, B. Beckmann, D. Langin, J. Jordan, and C. Moro Natriuretic peptides enhance the oxidative capacity of human skeletal muscle J Clin Invest 122 2012 4675 4679
20. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
21. K. Miyashita, H. Itoh, H. Tsujimoto, N. Tamura, Y. Fukunaga, M. Sone, K. Yamahara, D. Taura, M. Inuzuka, T. Sonoyama, and K. Nakao Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity Diabetes 58 2009 2880 2892
22. N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, M. Nishida, M. Kumada, Y. Okamoto, K. Ohashi, H. Nagaretani, K. Kishida, H. Nishizawa, N. Maeda, H. Kobayashi, H. Hiraoka, and Y. Matsuzawa Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
23. A.L. Birkenfeld, M. Boschmann, S. Engeli, C. Moro, A.M. Arafat, F.C. Luft, and J. Jordan Atrial natriuretic peptide and adiponectin interactions in man PLoS One 7 2012 e43238
24. R. Wolk, P. Berger, R.J. Lennon, E.S. Brilakis, D.E. Davison, and V.K. Somers Association between plasma adiponectin levels and unstable coronary syndromes Eur Heart J 28 2007 292 298
25. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737
26. S. Lindberg, R. Mogelvang, S.H. Pedersen, M. Bjerre, J. Frystyk, A. Flyvbjerg, S. Galatius, and J.S. Jensen Relation of serum adiponectin levels to number of traditional atherosclerotic risk factors and all-cause mortality and major adverse cardiovascular events (from the Copenhagen City Heart Study) Am J Cardiol 111 2013 1139 1145
27. T. Tsutamoto, T. Tanaka, H. Sakai, C. Ishikawa, M. Fujii, T. Yamamoto, and M. Horie Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure Eur Heart J 28 2007 1723 1730
28. W. Rathmann, and C. Herder Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology" Horm Metab Res 39 2007 1 2
29. S. Lindberg, J.S. Jensen, M. Bjerre, S.H. Pedersen, J. Frystyk, A. Flyvbjerg, and R. Mogelvang Cardio-adipose tissue crosstalk: relationship between adiponectin, plasma proBNP and incident heart failure Eur J Heart Fail 6 2014 633 638
30. M. Hayashi, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, T. Tsutsui, H. Horie, M. Ohnishi, and M. Kinoshita Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction J Am Coll Cardiol 37 2001 1820 1826